United Kingdom · Series B startup

Who invested in Blue Earth Diagnostics

One round we have observed, with the one investor named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Pharma

Funding summaryUpdated 26 Oct 2026

$28Mraised across 1 round since 2015, from 1 source

Latest round
Series B, $28MJul 2015
Investors
1
See who backed them

The rounds

  1. Jul 2015
    Series B$28M

    From a historical funding record

Founders and team

From Blue Earth Diagnostics's own website: 7 on the team.

  • Marco CampionePresident and Chief Executive Officer
  • Amy ParkerVice President Technical Operations
  • Charlie QuiricoSenior Vice President Global Commercial
  • Fabrizio FusiVice President Human Resources
  • Jonathan FitzpatrickVice President Innovation and Strategy
  • Michael WysockiSenior Vice President Global Commercial
  • Lori M. NickersonHead of Quality Assurance

Everyone who backed them

SynconaVC firm1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Blue Earth Diagnostics

Who invested in Blue Earth Diagnostics?

Blue Earth Diagnostics's investors include Syncona.

How much has Blue Earth Diagnostics raised?

Blue Earth Diagnostics has raised $28M across 1 round since 2015.

When did Blue Earth Diagnostics last raise?

Blue Earth Diagnostics's most recent round was a Series B of $28M in Jul 2015.

What was Blue Earth Diagnostics's biggest round?

Its most recent round, $28M in Jul 2015, is also its largest on record.

Who backed Blue Earth Diagnostics first?

Blue Earth Diagnostics's first round on record, in Jul 2015, was backed by Syncona.

What stage is Blue Earth Diagnostics at?

Blue Earth Diagnostics's latest named round is a Series B, in Jul 2015.

Where is Blue Earth Diagnostics based?

Blue Earth Diagnostics is based in the United Kingdom.

Companies like Blue Earth Diagnostics

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.